Non‐invasive diagnosis of early cutaneous squamous cell carcinoma
暂无分享,去创建一个
[1] Lewei Yang,et al. Glycosylated Cathepsin V Serves as a Prognostic Marker in Lung Cancer , 2022, Frontiers in Oncology.
[2] Guang Shan,et al. CTSV (cathepsin V) promotes bladder cancer progression by increasing NF-κB activity , 2022, Bioengineered.
[3] Xin Xu,et al. Long noncoding RNA MIR210HG is induced by hypoxia-inducible factor 1α and promotes cervical cancer progression. , 2022, American journal of cancer research.
[4] Ali Azimi,et al. Specialised skin cancer spectral library for use in data‐independent mass spectrometry , 2021, Proteomics.
[5] Ali Azimi,et al. Mass spectrometry‐based proteomic analysis of the effect of storage temperature on non‐invasively collected samples of human stratum corneum , 2021, Proteomics. Clinical applications.
[6] G. Lalmanach,et al. Cystatin M/E (Cystatin 6): A Janus-Faced Cysteine Protease Inhibitor with Both Tumor-Suppressing and Tumor-Promoting Functions , 2021, Cancers.
[7] Joachim Goedhart,et al. VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots , 2020, Scientific Reports.
[8] K. Lo,et al. Investigating proteome changes between primary and metastatic cutaneous squamous cell carcinoma using SWATH mass spectrometry. , 2020, Journal of dermatological science.
[9] G. Mann,et al. Data independent acquisition proteomic analysis can discriminate between actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma. , 2020, The Journal of investigative dermatology.
[10] Roland Bruderer,et al. Surpassing 10 000 identified and quantified proteins in a single run by optimizing current LC-MS instrumentation and data analysis strategy. , 2019, Molecular omics.
[11] Kylie L. Gorringe,et al. Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ , 2019, Journal of Clinical Pathology.
[12] P. A. Futreal,et al. Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases. , 2019, Cancer discovery.
[13] G. Walko,et al. The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin , 2019, Cells.
[14] N. Tan,et al. Reactive oxygen species: a volatile driver of field cancerization and metastasis , 2019, Molecular Cancer.
[15] G. Mann,et al. Tape Stripped Stratum Corneum Samples Prove to be Suitable for Comprehensive Proteomic Investigation of Actinic Keratosis , 2018, Proteomics. Clinical applications.
[16] J. Arthur,et al. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS. , 2018, Journal of dermatological science.
[17] S. Seo,et al. Features Causing Confusion between Basal Cell Carcinoma and Squamous Cell Carcinoma in Clinical Diagnosis , 2017, Annals of dermatology.
[18] V. Parekh,et al. Cutaneous Squamous Cell Carcinoma. , 2017, Clinics in laboratory medicine.
[19] M. Abrahamson,et al. Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells , 2017, The Journal of Biological Chemistry.
[20] John Quackenbush,et al. WebMeV: a Cloud Platform for Analyzing and Visualizing Cancer Genomic Data , 2017, bioRxiv.
[21] S. Prasad,et al. Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals. , 2017, Cancer letters.
[22] Masaki Matsumoto,et al. jPOSTrepo: an international standard data repository for proteomes , 2016, Nucleic Acids Res..
[23] Kimberley Louise Kaufman Alexander-Kaufman,et al. In Silico Analysis Validates Proteomic Findings of Formalin-fixed Paraffin Embedded Cutaneous Squamous Cell Carcinoma Tissue. , 2016, Cancer genomics & proteomics.
[24] Marco Y. Hein,et al. The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.
[25] Andrew D. Rouillard,et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..
[26] T. Sugino,et al. Liver X receptor reduces proliferation of human oral cancer cells by promoting cholesterol efflux via up-regulation of ABCA1 expression , 2015, Oncotarget.
[27] George Garib,et al. Actinic Keratosis, Transected: What Lies Beneath? , 2015, The American Journal of dermatopathology.
[28] E. Petricoin,et al. Activation of the PI3K/Akt/mTOR and MAPK Signaling Pathways in Response to Acute Solar-Simulated Light Exposure of Human Skin , 2015, Cancer Prevention Research.
[29] Ju Liu,et al. CD109 expression is increased in cutaneous squamous cell carcinoma , 2014, Journal of dermatology (Print).
[30] Alvin L. K. Chia,et al. Actinic Keratosis: Rationale and Management , 2014, Dermatology and Therapy.
[31] Andreas Krämer,et al. Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..
[32] Edward Y. Chen,et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.
[33] A. Indra,et al. Nuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesis , 2013, FEBS letters.
[34] L. Mullenders,et al. Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients , 2013, BMC Cancer.
[35] Yongli Zhang,et al. Support Vector Machine Classification Algorithm and Its Application , 2012, ICICA.
[36] J. Leonardi-Bee,et al. A systematic review of worldwide incidence of nonmelanoma skin cancer , 2012, The British journal of dermatology.
[37] I. R. Ruiz,et al. Genomic instability in human actinic keratosis and squamous cell carcinoma , 2011, Clinics.
[38] M. Kaplan,et al. Risk of Non-melanoma Skin Cancer in Autoimmune Hepatitis , 2010, Digestive Diseases and Sciences.
[39] Kenneth H. Buetow,et al. PID: the Pathway Interaction Database , 2008, Nucleic Acids Res..
[40] A. Torres,et al. Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll‐like receptor‐7 agonist imiquimod , 2007, The British journal of dermatology.
[41] Stephen J. Callister,et al. Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics. , 2006, Journal of proteome research.
[42] P. Harrigan. Skin cancer in Australia. , 1995, Lancet.
[43] M. Scholtz. PRECANCEROUS skin lesions. , 1923, Cancer Bulletin.
[44] Xinmin Li,et al. Author Index to Abstracts , 2011, Modern Pathology.
[45] E. Chroni,et al. Neuromuscular Adverse Effects Associated with Systemic Retinoid Dermatotherapy , 2010, Drug safety.
[46] Raktim Sinha,et al. MeV: MultiExperiment Viewer , 2010 .
[47] S. Meri,et al. TUMORIGENESIS AND NEOPLASTIC PROGRESSION Complement Component C 3 and Complement Factor B Promote Growth of Cutaneous Squamous Cell Carcinoma , 2022 .